Literature DB >> 11448846

Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats.

J J Hwa1, L Ghibaudi, J Gao, E M Parker.   

Abstract

Melanocortins play a critical role in appetite and body weight regulation, because manipulations of this pathway can lead to the development of obesity in several animal models. The purpose of this study was to use a melanocortin receptor agonist and antagonist to evaluate the involvement of melanocortins in feeding, energy metabolism, and body weight regulation in lean and obese Zucker rats. Central administration of a melanocortin receptor antagonist (SHU9119) elevated food intake and body weight of lean Zucker rats but had little effect in obese Zucker rats. In contrast, the melanocortin receptor agonist MTII reduced food intake in both lean and obese rats but was more potent in the obese Zucker rats. These data indicate the existence of functional melanocortin receptors in both lean and obese Zucker rats but suggest that obese Zucker rats have reduced endogenous melanocortin tone. In addition to its effects on food intake, MTII infusion elevated oxygen consumption and decreased respiratory quotient dose dependently during the light cycle. Our data suggest that a melanocortin receptor agonist can induce weight loss by increasing energy expenditure and promoting body fat utilization in addition to its inhibitory effects on food intake in both obese and lean Zucker rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448846     DOI: 10.1152/ajpregu.2001.281.2.R444

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  20 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity.

Authors:  Y Zhang; E Rodrigues; Y X Gao; M King; K Y Cheng; B Erdös; N Tümer; C Carter; P J Scarpace
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

3.  Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats.

Authors:  Jussara M do Carmo; Alexandre A da Silva; John S Rushing; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-28       Impact factor: 3.619

Review 4.  The melanocortin system and energy balance.

Authors:  Andrew A Butler
Journal:  Peptides       Date:  2006-01-23       Impact factor: 3.750

5.  Maternal nutrition and the programming of obesity: The brain.

Authors:  Beverly Sara Mühlhäusler; Clare L Adam; I Caroline McMillen
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

Review 6.  Hypothalamic-autonomic control of energy homeostasis.

Authors:  Patricia Seoane-Collazo; Johan Fernø; Francisco Gonzalez; Carlos Diéguez; Rosaura Leis; Rubén Nogueiras; Miguel López
Journal:  Endocrine       Date:  2015-06-19       Impact factor: 3.633

Review 7.  Structure, function and regulation of the melanocortin receptors.

Authors:  Yingkui Yang
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

8.  Simultaneous POMC gene transfer to hypothalamus and brainstem increases physical activity, lipolysis and reduces adult-onset obesity.

Authors:  Yi Zhang; Enda Rodrigues; Gang Li; Yongxin Gao; Michael King; Christy S Carter; Nihal Tumer; Kit-Yan Cheng; Philip J Scarpace
Journal:  Eur J Neurosci       Date:  2011-03-02       Impact factor: 3.386

9.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

10.  Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins.

Authors:  Karolina P Skibicka; Harvey J Grill
Journal:  Endocrinology       Date:  2009-10-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.